Shigeto Ueda

2.5k total citations
43 papers, 1.4k citations indexed

About

Shigeto Ueda is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research. According to data from OpenAlex, Shigeto Ueda has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Shigeto Ueda's work include Breast Cancer Treatment Studies (13 papers), Medical Imaging Techniques and Applications (11 papers) and Optical Imaging and Spectroscopy Techniques (10 papers). Shigeto Ueda is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Medical Imaging Techniques and Applications (11 papers) and Optical Imaging and Spectroscopy Techniques (10 papers). Shigeto Ueda collaborates with scholars based in Japan, United States and Switzerland. Shigeto Ueda's co-authors include Hitoshi Tsuda, Takashi Shigekawa, Hidetaka Mochizuki, Akihiko Osaki, Osamu Matsubara, Kazuhiko Fukatsu, Ichiei Kuji, Hideki Asakawa, Jiro Ishida and Yoshiyuki Abe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shigeto Ueda

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shigeto Ueda Japan	20	611	531	508	267	239	43	1.4k
C. Cuvier France	19	594 1.0×	629 1.2×	668 1.3×	231 0.9×	85 0.4×	49	1.6k
In-Ae Park South Korea	24	627 1.0×	241 0.5×	509 1.0×	228 0.9×	113 0.5×	66	1.5k
Eren D. Yeh United States	23	1.0k 1.7×	460 0.9×	740 1.5×	167 0.6×	197 0.8×	57	1.9k
June‐Key Chung South Korea	24	704 1.2×	328 0.6×	242 0.5×	235 0.9×	63 0.3×	58	1.4k
Takashi Shigekawa Japan	18	286 0.5×	344 0.6×	433 0.9×	262 1.0×	67 0.3×	45	962
Jianjun Liu China	18	510 0.8×	317 0.6×	247 0.5×	177 0.7×	64 0.3×	68	1.0k
Samuele Massarut Italy	21	316 0.5×	558 1.1×	794 1.6×	292 1.1×	62 0.3×	67	1.5k
Knut Håkon Hole Norway	20	451 0.7×	351 0.7×	244 0.5×	285 1.1×	57 0.2×	51	1.2k
Sze Ting Lee Australia	20	633 1.0×	335 0.6×	235 0.5×	128 0.5×	79 0.3×	69	1.2k
Andrea Pirzkall United States	16	276 0.5×	794 1.5×	446 0.9×	305 1.1×	150 0.6×	31	1.2k

Countries citing papers authored by Shigeto Ueda

Since Specialization

Citations

This map shows the geographic impact of Shigeto Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeto Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeto Ueda more than expected).

Fields of papers citing papers by Shigeto Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeto Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeto Ueda. The network helps show where Shigeto Ueda may publish in the future.

Co-authorship network of co-authors of Shigeto Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeto Ueda. A scholar is included among the top collaborators of Shigeto Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeto Ueda. Shigeto Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ueda, Shigeto, Toshiaki Saeki, Akihiko Osaki, Tomohiko Yamane, & Ichiei Kuji. (2017). Bevacizumab Induces Acute Hypoxia and Cancer Progression in Patients with Refractory Breast Cancer: Multimodal Functional Imaging and Multiplex Cytokine Analysis. Clinical Cancer Research. 23(19). 5769–5778. 67 indexed citations

Ueda, Shigeto, Takashi Sakurai, Takashi Shigekawa, et al.. (2017). Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety. International Journal of Clinical Oncology. 22(5). 880–886. 8 indexed citations

Ueda, Shigeto, Toshiaki Saeki, Hideki Takeuchi, et al.. (2016). In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab. British Journal of Cancer. 114(11). 1212–1218. 78 indexed citations

Ueda, Shigeto, Takashi Shigekawa, Hideki Takeuchi, et al.. (2016). Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using ¹⁸F-FDG PET/CT. Journal of Nuclear Medicine. 57(8). 1189–1195. 16 indexed citations

Shimada, Hiroko, Shigeto Ueda, Toshiaki Saeki, et al.. (2015). Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety. Japanese Journal of Clinical Oncology. 45(7). 642–649. 15 indexed citations

Shigekawa, Takashi, Akihiko Osaki, Hiroshi Sekine, et al.. (2015). Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study. BMC Cancer. 15(1). 253–253. 4 indexed citations

Ueda, Shigeto, Ichiei Kuji, Takashi Shigekawa, et al.. (2014). Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients. PLoS ONE. 9(6). e98715–e98715. 19 indexed citations

Ueda, Shigeto & Toshiaki Saeki. (2014). Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy. Breast Cancer. 21(6). 776–779. 2 indexed citations

Ueda, Shigeto, Takashi Shigekawa, Hideki Takeuchi, et al.. (2014). Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy. Cancer Science. 105(7). 833–839. 11 indexed citations

10.

Ueda, Shigeto, Kazuo Matsuura, Takashi Shigekawa, et al.. (2013). Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast. BMC Cancer. 13(1). 514–514. 25 indexed citations

11.

Ueda, Shigeto, Toshiaki Saeki, Takashi Shigekawa, et al.. (2011). 18F-Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response. International Journal of Clinical Oncology. 17(3). 276–282. 23 indexed citations

12.

Ueda, Shigeto, et al.. (2010). Abstract P5-01-07: Oxyhemoglobin Flare after the First Day of Neoadjuvant Breast Cancer Chemotherapy Predicts Overall Response. Cancer Research. 70(24_Supplement). P5–1. 2 indexed citations

13.

Kobayashi, Takayuki, Hitoshi Tsuda, Tomoyuki Moriya, et al.. (2009). Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis. Breast Cancer Research and Treatment. 123(3). 733–745. 26 indexed citations

14.

Sasaki, Yuka, Hitoshi Tsuda, Shigeto Ueda, et al.. (2009). Histological differences between invasive ductal carcinoma with a large central acellular zone and matrix‐producing carcinoma of the breast. Pathology International. 59(6). 390–394. 7 indexed citations

15.

Ueda, Shigeto, Hitoshi Tsuda, Hideki Asakawa, et al.. (2008). Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer. Japanese Journal of Clinical Oncology. 38(4). 250–258. 187 indexed citations

16.

Ueda, Shigeto, Hitoshi Tsuda, Hideki Asakawa, et al.. (2008). Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer. 8(1). 165–165. 108 indexed citations

17.

Shigekawa, Takashi, Hitoshi Tsuda, Shigeto Ueda, et al.. (2007). Squamous cell carcinoma of the breast in the form of an intracystic tumor. Breast Cancer. 14(1). 109–112. 25 indexed citations

18.

Sato, Kazuhiko, et al.. (2007). Sentinel lymph node biopsy for breast cancer. Journal of Surgical Oncology. 96(4). 322–329. 17 indexed citations

19.

Ueda, Shigeto, Kazuo Hatsuse, Hitoshi Tsuda, et al.. (2006). Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer. Modern Pathology. 19(6). 788–796. 42 indexed citations

20.

Ueda, Shigeto, Sho Ogata, Hitoshi Tsuda, et al.. (2004). The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor Aggressiveness. Pancreas. 29(1). e1–e8. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact